Professor, Radiation Oncology, Washington University in St. Louis School of Medicine
Radiation Oncology
Dr. Jeffrey D. Bradley, MD
|
|
Give Review
Jeffrey Bradley is an expert in the field of Radiation Oncology. He went to medical school at University of Arkansas for Medical Sciences College of Medicine. University of Arkansas for Medical Sciences College of Medicine has a rank of 83 in research and a 35 in primary care He received 4 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Top MD". Jeffrey Bradley is a published doctor and has 67 publications published. The lastest was: 'Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.'
Publications
- The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
- Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
- Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
- Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung...
- Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235.
- Concurrent pemetrexed and radiation therapy in the treatment of patients with inoperable stage III non-small cell lung cancer: A systematic review of completed and ong...
- Postoperative radiotherapy for pathologic n2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the national cancer data base.
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage I...
- PET-Based Radiation Therapy Planning.
- Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3.
- ACR Appropriateness Criteria(®) Pre-Irradiation Evaluation and Management of Brain Metastases.
- National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non-Small-Cell Lung Cancer.
- No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early- Stage Peripheral Non-Small Cell Lung Cancer: An Analys...
- Prospective study evaluating the use of IV contrast on IMRT treatment planning for lung cancer.
- Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
- Physiologically guided approach to characterizing respiratory motion.
- A Phase I Study of Temsirolimus and Thoracic Radiation in Non-Small-Cell Lung Cancer.
- Distribution of lung tissue hysteresis during free breathing.
- The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy ...
- Treatment of stage I lung cancer in high-risk and inoperable patients: Comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), subl...
- Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer.
- Eliminating inconsistencies in simulation and treatment planning orders in radiation therapy.
- Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma...
- Stereotactic body radiation therapy in the treatment of multiple primary lung cancers.
- A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: A decision analysis.
- Combined PET/CT image characteristics for radiotherapy tumor response in lung cancer.
- Modeling the Risk of Radiation-Induced Acute Esophagitis for Combined Washington University and RTOG Trial 93-11 Lung Cancer Patients.
- Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer.
- A bioinformatics approach for biomarker identification in radiation-induced lung inflammation from limited proteomics data.
- Investigation of a breathing surrogate prediction algorithm for prospective pulmonary gating.
- Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial Plexus.
- Clinical perspectives on dose escalation for non-small-cell lung cancer.
- Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
- Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
- The treatment of early-stage disease.
- A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of R...
- Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy f...
- Radiation dose-volume effects in the lung.
- Application of the continuity equation to a breathing motion model.
- Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: A timeline and pattern of CT changes.
- Characterization of free breathing patterns with 5D lung motion model.
- Bioinformatics methods for learning radiation-induced lung inflammation from heterogeneous retrospective and prospective data.
- Bronchoscopic implantation of a novel wireless electromagnetic transponder in the canine lung: a feasibility study.
- Effect of novel amplitude/phase binning algorithm on commercial four-dimensional computed tomography quality.
- Concurrent multimodality image segmentation by active contours for radiotherapy treatment planning.
- Assessment of intrafraction mediastinal and hilar lymph node movement and comparison to lung tumor motion using four-dimensional CT.
- Retrospective monte carlo dose calculations with limited beam weight information.
- 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?
- Deblurring of breathing motion artifacts in thoracic PET images by deconvolution methods.
- A semi-automatic method for peak and valley detection in free-breathing respiratory waveforms.
- Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
- A comparison between amplitude sorting and phase-angle sorting using external respiratory measurement for 4D CT.
- Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
- Novel breathing motion model for radiotherapy.
- Reduction of motion blurring artifacts using respiratory gated CT in sinogram space: a quantitative evaluation.
- Comparison of spirometry and abdominal height as four-dimensional computed tomography metrics in lung.
- Quantitation of the reconstruction quality of a four-dimensional computed tomography process for lung cancer patients.
- Positron emission tomography in limited-stage small-cell lung cancer: a prospective study.
- Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
- Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.
- A method for the reconstruction of four-dimensional synchronized CT scans acquired during free breathing.
- Molecular (functional) imaging for radiotherapy applications: an RTOG symposium.
- Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
- The impact of central lung distance, maximal heart distance, and radiation technique on the volumetric dose of the lung and heart for intact breast radiation.
- A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 9...
- Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
Schools
University Of Arkansas For Medical Sciences College Of Medicine Uams University Of Arkansas For Medical Sciences
Evanston Hospital
University of Chicago
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Top MD
Education
-
University of Chicago -
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1699793232 | |
| NPPES Provider LastName | BRADLEY | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 54.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1699793232 |
| Last Name Of The Provider | BRADLEY |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Delia M. Garcia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaymeson S. Stroud, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis E. Hallahan, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James E. Marks, MD |
|
|
Dr. Frederick R. Zivnuska, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anupama Chundury, MD |
|
|
Dr. Jiayi Huang, MD |
|
|
Dr. Stephanie Markovina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Frazier, MD
This Doctor is OpenDoctor Recommended.
|